Institute Marqués de Valdecilla (IDIVAL)
Carmen Alvarez-Dominguez has completed her Ph.D at the age of 29 years from Universidad Autonoma de Madrid and postdoctoral studies from Washington University School of Medicine on Small GTPases role in Listeria monocytogenes phagocytosis. She is the director of the Group on Genomics, Proteomics and Vaccines at the Research Institute Marqués de Valdecilla (IDIVAL) in Santander, Spain. She has published more than 29 papers in reputed journals and serving as an editorial board member of Microbes and Infection and OMICS. She also is coauthor of the patent: Immunogenic peptides against Listeria and Mycobacterium, antibodies and their uses with reference PCT/ES2007/070144.